Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medicinal cannabis for symptom relief in advanced cancer
ACTRN12619000265178Phase 4Recruiting
- Sponsor
- Health Administration Corporation
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dronabinol and cannabidiol in cancer (2 arms), sponsored by Health Administration Corporation. Primary endpoints: Overall quality of life, Pharmacokinetics of THC and CBD formulations and 1 more. Started Feb 2020; status: recruiting.
02
Drugs
dronabinolcannabidiol
03
Conditions
cancer
Beyond the preview
Go deeper on ACTRN12619000265178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619000265178.